These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7543818)

  • 1. Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis.
    Nelson J; Allen WE; Scott WN; Bailie JR; Walker B; McFerran NV; Wilson DJ
    Cancer Res; 1995 Sep; 55(17):3772-6. PubMed ID: 7543818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo.
    Grant DS; Kinsella JL; Fridman R; Auerbach R; Piasecki BA; Yamada Y; Zain M; Kleinman HK
    J Cell Physiol; 1992 Dec; 153(3):614-25. PubMed ID: 1280280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laminin SIKVAV peptide-induced angiogenesis in vivo is potentiated by neutrophils.
    Kibbey MC; Corcoran ML; Wahl LM; Kleinman HK
    J Cell Physiol; 1994 Jul; 160(1):185-93. PubMed ID: 7517404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J; Huang S; Armstrong EA; Fowler JF; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro.
    Sato Y; Okamura K; Morimoto A; Hamanaka R; Hamaguchi K; Shimada T; Ono M; Kohno K; Sakata T; Kuwano M
    Exp Cell Res; 1993 Feb; 204(2):223-9. PubMed ID: 7679996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
    Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
    Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.
    Yao L; Pike SE; Tosato G
    J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha(3)beta(1) and alpha(6)beta(4) integrins.
    Pouliot N; Nice EC; Burgess AW
    Exp Cell Res; 2001 May; 266(1):1-10. PubMed ID: 11339819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis.
    Moon EJ; Lee YM; Kim KW
    Oncol Rep; 2003; 10(3):617-21. PubMed ID: 12684633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine epidermal growth factor peptide (33-42) binds to a YIGSR-specific laminin receptor on both tumor and endothelial cells.
    Nelson J; Scott WN; Allen WE; Wilson DJ; Harriott P; McFerran NV; Walker B
    J Biol Chem; 1996 Oct; 271(42):26179-86. PubMed ID: 8824265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic murine epidermal growth factor sequence 20-31 is mitogenic and angiogenic.
    Nelson J; Stewart R; McGivern M; Bailie JR; Walker B; Murphy RF; Wilson DJ
    Carcinogenesis; 1991 Oct; 12(10):1823-9. PubMed ID: 1718617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
    Iwasaka C; Tanaka K; Abe M; Sato Y
    J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
    Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.